Literature DB >> 26407208

Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles.

Zeinab M A Fathalla1,2, Khaled A Khaled1, Amal K Hussein1, Raid G Alany2,3, Anil Vangala2.   

Abstract

The aim of this work was to formulate chitosan (CS)-based nanoparticles (NPs) loaded with ketorolac tromethamine (KT) intended for topical ocular delivery. NPs were prepared using ionic gelation method incorporating tri-polyphosphate (TPP) as cross-linker. Following the preparation, the composition of the system was optimized in terms of their particle size, zeta potential, entrapment efficiency (EE) and morphology, as well as performing structural characterization studies using Fourier transform infrared spectroscopy (FT-IR) and differential scanning calorimetry (DSC). The data suggested that the size of the NPs was affected by CS/TPP ratio where the diameter of the NPs ranged from 108.0 ± 2.4 nm to 257.2 ± 18.6 nm. A correlation between drug EE and the corresponding drug concentration added to the formulation was observed, where the EE of the NPs increased with increasing drug concentration, for up to 10 mg/mL. FT-IR and DSC revealed that KT was dispersed within the NPs where the phosphate groups of TPP were associated with the ammonium groups of CS. The in vitro release profile of KT from CS NPs showed significant differences (p < 0.05) compared to KT solution. Furthermore, mucoadhesion studies revealed adhesive properties of the formulated NPs. The KT-loaded NPs were found to be stable when stored at different storage conditions for a period of 3 months. The ex vivo corneal permeation studies performed on excised porcine eye balls confirmed the ability of NPs in retaining the drug on the eye surface for a relatively longer time. These results demonstrate the potential of CS-based NPs for the ocular delivery of KT.

Entities:  

Keywords:  Ionotropic gelation; mucoadhesion; ocular delivery; stability; tri-polyphosphate

Mesh:

Substances:

Year:  2015        PMID: 26407208     DOI: 10.3109/03639045.2015.1081236

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  6 in total

Review 1.  Nanoparticles for drug delivery to the anterior segment of the eye.

Authors:  Dileep R Janagam; Linfeng Wu; Tao L Lowe
Journal:  Adv Drug Deliv Rev       Date:  2017-04-06       Impact factor: 15.470

Review 2.  Evolution of Nanotechnology in Delivering Drugs to Eyes, Skin and Wounds via Topical Route.

Authors:  Pratheeksha Koppa Raghu; Kuldeep K Bansal; Pradip Thakor; Valamla Bhavana; Jitender Madan; Jessica M Rosenholm; Neelesh Kumar Mehra
Journal:  Pharmaceuticals (Basel)       Date:  2020-07-27

3.  Formulation, optimization and characterization of allantoin-loaded chitosan nanoparticles to alleviate ethanol-induced gastric ulcer: in-vitro and in-vivo studies.

Authors:  Reham Mokhtar Aman; Randa A Zaghloul; Marwa S El-Dahhan
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

4.  Effective Ocular Delivery of Eplerenone Using Nanoengineered Lipid Carriers in Rabbit Model.

Authors:  Eman Abdelhakeem; Mohamed El-Nabarawi; Rehab Shamma
Journal:  Int J Nanomedicine       Date:  2021-07-22

5.  Useful In Vitro Techniques to Evaluate the Mucoadhesive Properties of Hyaluronic Acid-Based Ocular Delivery Systems.

Authors:  Angélica Graça; Lídia Maria Gonçalves; Sara Raposo; Helena Margarida Ribeiro; Joana Marto
Journal:  Pharmaceutics       Date:  2018-08-01       Impact factor: 6.321

6.  Studies on Surfactants, Cosurfactants, and Oils for Prospective Use in Formulation of Ketorolac Tromethamine Ophthalmic Nanoemulsions.

Authors:  Shahla S Smail; Mowafaq M Ghareeb; Huner K Omer; Ali A Al-Kinani; Raid G Alany
Journal:  Pharmaceutics       Date:  2021-03-30       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.